Cross-linked guar gum hydrogel discs for colon-specific delivery of ibuprofen: Formulation and in vitro evaluation

Show simple item record

dc.contributor.author Das, A.
dc.contributor.author Wadhwa, S.
dc.contributor.author Srivastava, A.K.
dc.date.accessioned 2021-09-15T07:40:35Z
dc.date.available 2021-09-15T07:40:35Z
dc.date.issued 2006-03-01
dc.identifier.issn 15210464
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/1691
dc.description.abstract Hydrogel discs of guar gum cross-linked with glutaraldehyde were prepared as vehicles for colon-specific drug delivery. Ibuprofen was chosen as model drug. The discs were evaluated for such parameters as size, shape, weight, and drug loading. Swelling (buffer uptake) and in vitro drug release study, in presence and absence of rat caecal contents, was performed in simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 7.4) to evaluate the effect of various formulation parameters like guar gum concentration, amount of cross-linking agent, and cross-linking time on drug release. Cross-linking resulted in significant reduction in swelling of guar gum. Significant increase in drug release was observed in medium containing rat caecal content. Percent drug release increased with increasing glutaraldehyde concentration. Cross-linking time and guar gum concentration did not have any significant effect on drug release in the range studied. en_US
dc.description.sponsorship Drug Delivery en_US
dc.language.iso en en_US
dc.relation.ispartofseries Issue 2;Volume 13
dc.subject Colon Delivery; en_US
dc.subject Cross-Linking; en_US
dc.subject Guar Gum; en_US
dc.subject Hydrogel; en_US
dc.subject Ibuprofen en_US
dc.title Cross-linked guar gum hydrogel discs for colon-specific delivery of ibuprofen: Formulation and in vitro evaluation en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search in IDR


Advanced Search

Browse

My Account